新华医疗SHINVA品牌怎么样 申请店铺

更新时间:2024-09-20
新华医疗SHINVA是哪个国家的品牌?「新华医疗SHINVA」是 山东新华医疗器械股份有限公司 旗下著名品牌。该品牌发源于山东省淄博市,由创始人赵董在1943年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
新华医疗SHINVA怎么样

山东新华医疗器械股份有限公司,创建于1943年,上市公司,专注于医疗器械及装备/制药装备/医疗服务的高新技术企业


2002年9月,山东新华医疗器械股份有限公司在上海证券交易所上市,现为中国医疗器械行业协会会长单位。

山东新华医疗器械股份有限公司始终坚持拼搏诚信的齐鲁文化、以用户为中心的现代企业文化为企业核心价值观,用目标鼓舞士气,用发展凝聚人心,用创新提升素质,用文化打造实力,坚定不移地走健康产业之路,坚定不移地走技术创新之路,坚定不移地走资本运作之路,拥有医疗器械及装备、制药装备、医疗服务三大业务板块。

在医疗器械板块,已形成九大配置精良、技术完备的先进产品线,涵盖感染控制、放疗及影像、手术器械及骨科、手术室工程及设备、口腔设备及耗材、体外诊断试剂及仪器、生物材料及耗材、透析设备及耗材、医用环保及其他领域。

制药装备板块,由生物制药、特种输液、中药制剂、固体制剂四大工程技术中心组成,下设八个产品技术分厂和五个控股公司,集制药装备研发、制造及销售为一体。在常规制药装备生产之外,提供着“制药工艺、制药装备、制药工程”三位一体的优质服务;同时,为化学药、生物药、植物药工厂的建设提供整包服务,为客户解决一切后顾之忧。

在医疗服务领域,新华医疗持续提升着品牌竞争力和美誉度。凭借专业的投资、建设、运营及采购和服务平台,打造具有先进医疗理念、前沿科研水平、品牌经营连锁、资源有机融合的现代化医院集团。与此同时,新华医疗也在积极拓展着肾脏健康服务,利用公司专业化、集约化、连锁化的运营优势,为医院提供新技术、新管理、新模式,创建出一系列特色鲜明的肾脏病专科医院和血液透析中心,用无限的责任感和专业度,服务于广大肾病患者。未来,新华医疗,将以集团化、专业化、规范化的全新面貌,为更多患者提供完善医疗服务,成就发展健康产业之路的宏伟梦想。

公司以山东核心区域为研发、制造、营销和管理总部,同时有北京核心区域、上海核心区域。

心系健康,诚信天下。站在新的历史起点上,面对新的发展机遇,新华医疗将一如既往,与时俱进,以自信、创新和拼搏,去勇敢面对困难和挑战,为人类健康事业、为铸造中国医疗器械产业的丰碑、打造世界知名医疗器械生产企业而继续努力奋斗!


Shandong Xinhua medical device Co., Ltd., founded in 1943, is a listed company. In September 2002, Shandong Xinhua medical device Co., Ltd. was listed on Shanghai Stock Exchange. Now it is the chairman of China Medical Device Industry Association. Shandong Xinhua Medical Equipment Co., Ltd. always adheres to the Qilu culture of striving for integrity, the modern enterprise culture centered on users as the core values of the enterprise, encourages morale with goals, rallies people with development, improves quality with innovation, builds strength with culture, firmly takes the road of health industry, firmly takes the road of technological innovation, and firmly takes the road of capital The way of operation, with medical devices and equipment, pharmaceutical equipment, medical services three business sectors. In the medical equipment sector, nine advanced product lines with excellent configuration and complete technology have been formed, covering infection control, radiotherapy and imaging, surgical equipment and orthopedics, operating room engineering and equipment, oral equipment and consumables, in vitro diagnostic reagents and instruments, biomaterials and consumables, dialysis equipment and consumables, medical environmental protection and other fields. The pharmaceutical equipment sector is composed of four engineering technology centers, including biopharmaceutical, special infusion, traditional Chinese medicine preparation and solid preparation. It has eight product technology branches and five holding companies, integrating the R & D, manufacturing and sales of pharmaceutical equipment. In addition to the production of conventional pharmaceutical equipment, it provides the high-quality service of "pharmaceutical technology, pharmaceutical equipment, pharmaceutical engineering"; at the same time, it provides the whole package service for the construction of chemical medicine, biological medicine, plant medicine factories, and solves all the worries for customers. In the field of medical services, Xinhua medical continues to enhance its brand competitiveness and reputation. With professional investment, construction, operation, procurement and service platform, we will build a modern hospital group with advanced medical concept, cutting-edge scientific research level, brand management chain and organic integration of resources. At the same time, Xinhua medical is also actively expanding kidney health services, taking advantage of the company's professional, intensive and chain operation advantages to provide new technology, new management and new mode for the hospital, creating a series of distinctive kidney disease specialized hospitals and hemodialysis centers, serving the vast number of nephrotic patients with unlimited sense of responsibility and professionalism. In the future, Xinhua medical will take a new look of collectivization, specialization and standardization to provide more patients with perfect medical services and achieve the grand dream of developing health industry. The company takes the core area of Shandong Province as its R & D, manufacturing, marketing and management headquarters, and has the core areas of Beijing and Shanghai. Heart health, integrity world. Standing at a new historical starting point and facing new development opportunities, Xinhua medical will, as always, keep pace with the times, bravely face difficulties and challenges with self-confidence, innovation and hard work, and continue to strive for the cause of human health, the building of a monument of China's medical device industry and the building of a world-famous medical device manufacturer!

本文链接: https://brand.waitui.com/e029c4041.html 联系电话:400-158-3393,0533-3583393

千城特选小程序码

7×24h 快讯

ST曙光:控股子公司收到国家新能源客车推广应用补贴

36氪获悉,ST曙光发布公告,公司控股子公司黄海汽车收到丹东市财政局拨付的国家新能源客车推广应用补助资金700万元。截至公告披露日,公司已累计收到上述节能减排补助资金2143万元。此次收到的补贴款项将直接冲减黄海汽车的应收账款,不会影响当期损益,将对黄海汽车的现金流产生积极影响。

19分钟前

壳牌德国炼油厂股权出售面临延迟

市场消息:壳牌德国炼油厂股权出售面临延迟。(新浪财经)

19分钟前

爱奇艺调整网络电影分账时长阶梯标准

36氪获悉,9月18日,爱奇艺宣布将调整网络电影分账时长阶梯标准。自2024年10月1日起,所有独家上线爱奇艺平台的网络电影在会员分账周期內,将按照会员观看时长超600万、超200万和低于200万小时三个新阶梯,对应万小时阶梯每小时分账单价3元、2元和1元,最终收获各阶梯收益票房的总和。调整前的时长阶梯标准是超1000万、超600万和低于600万小时三档。

19分钟前

广州南沙区买房即可落户?回应:目前并无相关政策

针对广州南沙区“买房即可落户”的消息,9月19日,南沙区人社局相关工作人员回应,目前南沙区并无购买商品房后能够直接入户南沙的政策。(澎湃)

19分钟前

华菱精工:拟5000万元—1亿元回购公司股份

36氪获悉,华菱精工发布公告,公司拟以自有资金通过集中竞价交易方式回购股份,用于员工持股计划或股权激励,回购金额为5000万元至1亿元,回购股份的价格不超过17.43元/股(含)。

19分钟前

本页详细列出关于新华医疗SHINVA的品牌信息,含品牌所属公司介绍,新华医疗SHINVA所处行业的品牌地位及优势。
咨询